Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Catalogo dei prodotti della ricerca
Abstract
Background and Aims
Truncating variants in the TTN gene (TTNtv) are the most common genetic cause of dilated cardiomyopathy (DCM) but also occur as incidental findings in the general population. This study investigated factors associated with the clinical manifestation of TTNtv.
Methods
An international multicentre retrospective observational study was performed in families with TTNtv-related DCM. Shared frailty models were used to estimate associations of variant characteristics with lifetime risk of DCM, and logistic regression to estimate odds ratios (ORs) for individual-level clinical risk factor profiles (cardiac conditions, cardiovascular comorbidities, lifestyle) and DCM.
Results
A total of 3158 subjects in 1043 families with TTNtv-related DCM were studied. TTNtv-positive subjects were 21-fold more likely to develop DCM [OR, 21.21; 95% confidence interval (CI), 14.80–30.39]. Disease onset was earlier in males, but was similar for TTNtv of different types and locations. The presence of clinical risk factors was associated with earlier DCM onset (OR, 3.41; 95% CI, 2.06–5.64), with a prior history of atrial fibrillation having a two-fold increased odds of DCM (OR, 2.05; 95% CI, 1.27–3.32). The prevalence of clinical risk factors increased with age; however, the strength of the DCM association was greatest for young-onset (<30 years) disease (OR, 4.75; 95% CI, 2.35–9.60). Administration of beta-adrenergic receptor or renin-angiotensin system-blocking drugs prior to overt DCM was associated with 87% reduced odds of DCM (OR, .13; 95% CI, .08–.23).
Conclusions
Disease onset in TTNtv-associated familial DCM is dependent on individual patient context and is potentially modifiable by risk factor management and prophylactic therapeutic intervention.
Titin-related familial dilated cardiomyopathy: factors associated with disease onset / Johnson, Renee; A Fletcher, Robert; Peters, Stacey; Ohanian, Monique; Soka, Magdalena; Smolnikov, Andrei; E Abihider, Katherine; J Ackerman, Michael; Ader, Flavie; M Akhtar, Mohammed; S Amin, Ahmad; A Ashley, Euan; J Atherton, John; Austin, Rachel; F Baas, Annette; D Bagnall, Richard; Barratt Ross, Samantha; Blouin, Jean-Louis; E Brown, Emily; Bundgaard, Henning; Cannie, Douglas; Chmielewski, Przemyslaw; Correnti, Gemma; Generosa Crespo-Leiro, Maria; Dal Ferro, Matteo; M Dellefave-Castillo, Lisa; Dominguez, Fernando; Dooijes, Dennis; M Dybro, Anne; Ed Demri, Youssef; El Hachmi, Mohamed; Escobar-Lopez, Luis; Jajesnica Foye, Sarah; Franaszczyk, Maria; Gigli, Marta; Gonzalez Lopez, Esther; Goudal, Adeline; Graw, Sharon; Guipponi, Michel; Haan, Eric; Haas, Jan; J Hammersley, Daniel; G Hansen, Frederikke; S Hayward, Christopher; Morris Hey, Thomas; Heymans, Stephane; Y Ho, Carolyn; C Houweling, Arjan; Ingles, Jodie; Ingrey, Angela; Jabbour, Andrew; A James, Paul; A Jansweijer, Joeri; H Jongbloed, Jan D; M Keogh, Anne; M Larrañaga-Moreira, Jose; H Lekanne Deprez, Ronald; Macciocca, Ivan; S Macdonald, Peter; Mansencal, Nicolas; Mansour, Julia; Martinez-Veira, Cristina; Mcdonough, Barbara; Mcgaughran, Julie; Medo, Kristen; Merlo, Marco; Michalak, Ewa; Monserrat, Lorenzo; Mountain, Helen; A Muller, Steven; M Murphy, Anne; Murray, Brittney; C Oates, Emily; Ormondroyd, Elizabeth; Pachter, Nicholas; Paldino, Alessia; Palmyre, Aurélien; L Pereira, Naveen; C Picard, Kermshlise; Poplawski, Nicola; Prasad, Sanjay; Proukhnitzky, Julie; Pruny, Jean-Francois; Reant, Patricia; Richard, Pascale; Ronan, Anne; Sedaghat-Hamedani, Farbod; Semsarian, Christopher; Storm, Garrett; Stroeks, Sophie; Syrris, Petros; G Taylor, Matthew R; Thomson, Kate; Thompson, Tina; Peter Van Tintelen, J; Rasmus Vissing, Christoffer; E Waddell-Smith, Kathryn; Wallis, Mathew; Zentner, Dominica; Genomics Cardiac Flagship, Australian; Arnott, Clare; J Marian, Ali; Oh, Jaewon; Fokstuen, Siv; A James, Cynthia; Barriales-Villa, Roberto; Meder, Benjamin; Wahbi, Karim; R Giudicessi, John; N Parikh, Victoria; S Ware, James; Piriou, Nicolas; Rooryck, Caroline; K Lakdawala, Neal; Mestroni, Luisa; Sinagra, Gianfranco; M Elliott, Perry; Watkins, Hugh; M Mcnally, Elizabeth; Charron, Philippe; Y van Spaendonck-Zwarts, Karin; Garcia-Pavia, Pablo; Luisa Peña-Peña, Maria; Mogensen, Jens; Hoerby Christensen, Alex; T Bilińska, Zofia; B Rasmussen, Torsten; G Seidman, Jonathan; E Seidman, Christine; M Te Riele, Anneline S J; J Verdonschot, Job A; M Pinto, Yigal; Christiaans, Imke; Fatkin, Diane. - In: EUROPEAN HEART JOURNAL. - ISSN 1522-9645. - (2025).
Titin-related familial dilated cardiomyopathy: factors associated with disease onset
Renee Johnson;Robert A Fletcher;Stacey Peters;Monique Ohanian;Magdalena Soka;Andrei Smolnikov;Katherine E Abihider;Michael J Ackerman;Flavie Ader;Mohammed M Akhtar;Ahmad S Amin;Euan A Ashley;John J Atherton;Rachel Austin;Annette F Baas;Richard D Bagnall;Samantha Barratt Ross;Jean-Louis Blouin;Emily E Brown;Henning Bundgaard;Douglas Cannie;Przemyslaw Chmielewski;Gemma Correnti;Maria Generosa Crespo-Leiro;Matteo Dal Ferro;Lisa M Dellefave-Castillo;Fernando Dominguez;Dennis Dooijes;Anne M Dybro;Youssef Ed Demri;Mohamed El Hachmi;Luis Escobar-Lopez;Sarah Jajesnica Foye;Maria Franaszczyk;Marta Gigli;Esther Gonzalez Lopez;Adeline Goudal;Sharon Graw;Michel Guipponi;Eric Haan;Jan Haas;Daniel J Hammersley;Frederikke G Hansen;Christopher S Hayward;Thomas Morris Hey;Stephane Heymans;Carolyn Y Ho;Arjan C Houweling;Jodie Ingles;Angela Ingrey;Andrew Jabbour;Paul A James;Joeri A Jansweijer;Jan D H Jongbloed;Anne M Keogh;Jose M Larrañaga-Moreira;Ronald H Lekanne Deprez;Ivan Macciocca;Peter S Macdonald;Nicolas Mansencal;Julia Mansour;Cristina Martinez-Veira;Barbara McDonough;Julie McGaughran;Kristen Medo;Marco Merlo;Ewa Michalak;Lorenzo Monserrat;Helen Mountain;Steven A Muller;Anne M Murphy;Brittney Murray;Emily C Oates;Elizabeth Ormondroyd;Nicholas Pachter;Alessia Paldino;Aurélien Palmyre;Naveen L Pereira;Kermshlise C Picard;Nicola Poplawski;Sanjay Prasad;Julie Proukhnitzky;Jean-Francois Pruny;Patricia Reant;Pascale Richard;Anne Ronan;Farbod Sedaghat-Hamedani;Christopher Semsarian;Garrett Storm;Sophie Stroeks;Petros Syrris;Matthew R G Taylor;Kate Thomson;Tina Thompson;J Peter van Tintelen;Christoffer Rasmus Vissing;Kathryn E Waddell-Smith;Mathew Wallis;Dominica Zentner;Australian Genomics Cardiac Flagship;Clare Arnott;Ali J Marian;Jaewon Oh;Siv Fokstuen;Cynthia A James;Roberto Barriales-Villa;Benjamin Meder;Karim Wahbi;John R Giudicessi;Victoria N Parikh;James S Ware;Nicolas Piriou;Caroline Rooryck;Neal K Lakdawala;Luisa Mestroni;Gianfranco Sinagra;Perry M Elliott;Hugh Watkins;Elizabeth M McNally;Philippe Charron;Karin Y van Spaendonck-Zwarts;Pablo Garcia-Pavia;Maria Luisa Peña-Peña;Jens Mogensen;Alex Hoerby Christensen;Zofia T Bilińska;Torsten B Rasmussen;Jonathan G Seidman;Christine E Seidman;Anneline S J M te Riele;Job A J Verdonschot;Yigal M Pinto;Imke Christiaans;Diane Fatkin
2025
Abstract
Abstract
Background and Aims
Truncating variants in the TTN gene (TTNtv) are the most common genetic cause of dilated cardiomyopathy (DCM) but also occur as incidental findings in the general population. This study investigated factors associated with the clinical manifestation of TTNtv.
Methods
An international multicentre retrospective observational study was performed in families with TTNtv-related DCM. Shared frailty models were used to estimate associations of variant characteristics with lifetime risk of DCM, and logistic regression to estimate odds ratios (ORs) for individual-level clinical risk factor profiles (cardiac conditions, cardiovascular comorbidities, lifestyle) and DCM.
Results
A total of 3158 subjects in 1043 families with TTNtv-related DCM were studied. TTNtv-positive subjects were 21-fold more likely to develop DCM [OR, 21.21; 95% confidence interval (CI), 14.80–30.39]. Disease onset was earlier in males, but was similar for TTNtv of different types and locations. The presence of clinical risk factors was associated with earlier DCM onset (OR, 3.41; 95% CI, 2.06–5.64), with a prior history of atrial fibrillation having a two-fold increased odds of DCM (OR, 2.05; 95% CI, 1.27–3.32). The prevalence of clinical risk factors increased with age; however, the strength of the DCM association was greatest for young-onset (<30 years) disease (OR, 4.75; 95% CI, 2.35–9.60). Administration of beta-adrenergic receptor or renin-angiotensin system-blocking drugs prior to overt DCM was associated with 87% reduced odds of DCM (OR, .13; 95% CI, .08–.23).
Conclusions
Disease onset in TTNtv-associated familial DCM is dependent on individual patient context and is potentially modifiable by risk factor management and prophylactic therapeutic intervention.
01 Pubblicazione su rivista::01a Articolo in rivista
Titin-related familial dilated cardiomyopathy: factors associated with disease onset / Johnson, Renee; A Fletcher, Robert; Peters, Stacey; Ohanian, Monique; Soka, Magdalena; Smolnikov, Andrei; E Abihider, Katherine; J Ackerman, Michael; Ader, Flavie; M Akhtar, Mohammed; S Amin, Ahmad; A Ashley, Euan; J Atherton, John; Austin, Rachel; F Baas, Annette; D Bagnall, Richard; Barratt Ross, Samantha; Blouin, Jean-Louis; E Brown, Emily; Bundgaard, Henning; Cannie, Douglas; Chmielewski, Przemyslaw; Correnti, Gemma; Generosa Crespo-Leiro, Maria; Dal Ferro, Matteo; M Dellefave-Castillo, Lisa; Dominguez, Fernando; Dooijes, Dennis; M Dybro, Anne; Ed Demri, Youssef; El Hachmi, Mohamed; Escobar-Lopez, Luis; Jajesnica Foye, Sarah; Franaszczyk, Maria; Gigli, Marta; Gonzalez Lopez, Esther; Goudal, Adeline; Graw, Sharon; Guipponi, Michel; Haan, Eric; Haas, Jan; J Hammersley, Daniel; G Hansen, Frederikke; S Hayward, Christopher; Morris Hey, Thomas; Heymans, Stephane; Y Ho, Carolyn; C Houweling, Arjan; Ingles, Jodie; Ingrey, Angela; Jabbour, Andrew; A James, Paul; A Jansweijer, Joeri; H Jongbloed, Jan D; M Keogh, Anne; M Larrañaga-Moreira, Jose; H Lekanne Deprez, Ronald; Macciocca, Ivan; S Macdonald, Peter; Mansencal, Nicolas; Mansour, Julia; Martinez-Veira, Cristina; Mcdonough, Barbara; Mcgaughran, Julie; Medo, Kristen; Merlo, Marco; Michalak, Ewa; Monserrat, Lorenzo; Mountain, Helen; A Muller, Steven; M Murphy, Anne; Murray, Brittney; C Oates, Emily; Ormondroyd, Elizabeth; Pachter, Nicholas; Paldino, Alessia; Palmyre, Aurélien; L Pereira, Naveen; C Picard, Kermshlise; Poplawski, Nicola; Prasad, Sanjay; Proukhnitzky, Julie; Pruny, Jean-Francois; Reant, Patricia; Richard, Pascale; Ronan, Anne; Sedaghat-Hamedani, Farbod; Semsarian, Christopher; Storm, Garrett; Stroeks, Sophie; Syrris, Petros; G Taylor, Matthew R; Thomson, Kate; Thompson, Tina; Peter Van Tintelen, J; Rasmus Vissing, Christoffer; E Waddell-Smith, Kathryn; Wallis, Mathew; Zentner, Dominica; Genomics Cardiac Flagship, Australian; Arnott, Clare; J Marian, Ali; Oh, Jaewon; Fokstuen, Siv; A James, Cynthia; Barriales-Villa, Roberto; Meder, Benjamin; Wahbi, Karim; R Giudicessi, John; N Parikh, Victoria; S Ware, James; Piriou, Nicolas; Rooryck, Caroline; K Lakdawala, Neal; Mestroni, Luisa; Sinagra, Gianfranco; M Elliott, Perry; Watkins, Hugh; M Mcnally, Elizabeth; Charron, Philippe; Y van Spaendonck-Zwarts, Karin; Garcia-Pavia, Pablo; Luisa Peña-Peña, Maria; Mogensen, Jens; Hoerby Christensen, Alex; T Bilińska, Zofia; B Rasmussen, Torsten; G Seidman, Jonathan; E Seidman, Christine; M Te Riele, Anneline S J; J Verdonschot, Job A; M Pinto, Yigal; Christiaans, Imke; Fatkin, Diane. - In: EUROPEAN HEART JOURNAL. - ISSN 1522-9645. - (2025).
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1755095
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Citazioni
ND
ND
ND
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.